Atorvastatin Preferentially Reduces LDL-Associated Platelet-Activating Factor Acetylhydrolase Activity in Dyslipidemias of Type IIA and Type IIB
暂无分享,去创建一个
J. Goudevenos | M. Elisaf | E. Bairaktari | A. Tambaki | A. Tselepis | M. Chapman | V. Tsimihodimos | J. Chapman | S. Karabina | Cardiology | S. P. K. | Cardiology